Structural heart disease

When Is the Optimal Time for Aortic Valve Replacement? Impact of Acute Valvular Syndrome on Outcomes and Costs

According to the clinical presentation before aortic valve replacement (AVR), a new classification has recently been proposed:...

Dr. Juan Manuel Pérez - 14 October, 2025

Learn More

Structural heart disease

In Hospital Complications after Transcatheter Aortic Valve Replacement in Bicuspid vs. Tricuspid Aortic Valves: A Retrospective Cohort Study

Courtesy of Dr. Juan Manuel Pérez. Bicuspid aortic valves (BAV), present in 0,5 to 2% of the population,...

Dr. Juan Manuel Pérez - 1 October, 2025

Learn More

Structural heart disease

Is the Acceleration Time/Ejection Time Ratio Superior to the Mean Gradient in Predicting Clinical Outcomes After TAVR?

Courtesy of Dr. Juan Manuel Pérez. Traditionally, the mean gradient (MG) has been used to assess post-TAVR outcomes....

Dr. Juan Manuel Pérez - 29 September, 2025

Learn More

Coronary disease

Coronary Events after TAVI according to the FRANCE Registry

Between 30% and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present with coronary artery disease...

Dr. Andrés Rodríguez - 25 September, 2025

Learn More

Structural heart disease

Should Early Aortic Valve Replacement Be Indicated in Asymptomatic Severe Aortic Stenosis?

A Meta-Analysis of Randomized Clinical Trials. The management of aortic stenosis in asymptomatic patients remains a matter of...

Dr. Juan Manuel Pérez - 19 September, 2025

Learn More

Structural heart disease

Predilatation in Self-Expanding Valves

TAVI has become the treatment of choice in specific scenarios. However, predilatation (PRD) remains a matter of...

Dr. Carlos Fava - 16 September, 2025

Learn More

Other

Tricuspid Regurgitation, TriBicaval Registry

Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery...

Dr. Carlos Fava - 11 September, 2025

Learn More

Mitral valve

Edge-To-Edge Treatment with PASCAL: Are There Sex-Specific Differences?

Mitral regurgitation (MR) is a common valve disease associated with heart failure, hospitalizations, and mortality. In women, it...

Dr. Carlos Fava - 10 September, 2025

Learn More

Structural heart disease

When Is the Optimal Time for Aortic Valve Replacement? Impact of Acute Valvular Syndrome on Outcomes and Costs

In Hospital Complications after Transcatheter Aortic Valve Replacement in Bicuspid vs. Tricuspid Aortic Valves: A Retrospective Cohort Study

Is the Acceleration Time/Ejection Time Ratio Superior to the Mean Gradient in Predicting Clinical Outcomes After TAVR?

Coronary Events after TAVI according to the FRANCE Registry

Should Early Aortic Valve Replacement Be Indicated in Asymptomatic Severe Aortic Stenosis?

Predilatation in Self-Expanding Valves

Tricuspid Regurgitation, TriBicaval Registry

Edge-To-Edge Treatment with PASCAL: Are There Sex-Specific Differences?

Last News

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access